(VIANEWS) – NAVAMEDIC (NAVA.OL), SALMAR (SALM.OL), SPAREBANKEN ØST (SPOG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NAVAMEDIC (NAVA.OL)
72.2% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr-1.14.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
Volume
Today’s last reported volume for NAVAMEDIC is 263 which is 98.92% below its average volume of 24467.
Moving Average
NAVAMEDIC’s worth is way higher than its 50-day moving average of kr36.80 and way higher than its 200-day moving average of kr33.35.
More news about NAVAMEDIC.
2. SALMAR (SALM.OL)
54.3% sales growth and 18.21% return on equity
SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, the United States, Canada, Norway, rest of Europe, and internationally. It is involved in the broodfish, lumpfish, and smolt production activities; and marine-phase farming, harvesting, packaging, processing, and selling farmed salmon. The company sells its products to importers/exporters, processing companies, and retail chains through in-house sales force and/or through partners. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.
Earnings Per Share
As for profitability, SALMAR has a trailing twelve months EPS of kr17.49.
PE Ratio
SALMAR has a trailing twelve months price to earnings ratio of 24.76. Meaning, the purchaser of the share is investing kr24.76 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.
More news about SALMAR.
3. SPAREBANKEN ØST (SPOG.OL)
35.8% sales growth and 6.25% return on equity
Sparebanken Øst operates as a savings bank in Eastern Norway. The company offers financial products, such as savings, credit, and payment products; mortgages on homes; and debenture financing for second-hand cars, as well as services in the areas of financing, savings and investment, and money-transfer. It also distributes insurance, fund shares, interest rate hedging, and currency, as well as operates, manages, leases, and sells real estate properties. The company was founded in 1843 and is headquartered in Drammen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN ØST has a trailing twelve months EPS of kr6.62.
PE Ratio
SPAREBANKEN ØST has a trailing twelve months price to earnings ratio of 6.71. Meaning, the purchaser of the share is investing kr6.71 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.25%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 691.4M for the twelve trailing months.
More news about SPAREBANKEN ØST.
4. NORBIT (NORBT.OL)
33.5% sales growth and 19.45% return on equity
NORBIT ASA provides technology products and solutions. It operates through three segments: Oceans, Connectivity, and Product Innovation and Realization. The company designs and develops wideband multibeam sonars used for hydrographic and forward-looking applications, as well as for detection of advanced subsea leakage; and provides cable assemblies, electromechanical box builds, and business solutions. It also offers sensors and sensor platforms used for monitoring, detection, and reporting tasks; GuardPoint, a surveillance sonar used to detect underwater intruders; SafePoint that use to detect navigational obstacles; NORTrace, a software that simulates and graphs the underwater propagation of various sonar; SeaCOP software system for monitoring, detection, and emergency response for maritime and offshore operations; and security solutions for defense. In addition, the company provides high power underwater lights, power cabinets, and other sensor solutions for aquaculture industry. Further, it offers dedicated short-range communication (DSRC) technology for intelligent traffic systems and truck applications; global navigation satellite systems-based tolling and DSRC devices, and connectivity modules for smart tachographs; desktop readers; roadside units; and reclosable fasteners. The company was founded in 1980 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, NORBIT has a trailing twelve months EPS of kr0.48.
PE Ratio
NORBIT has a trailing twelve months price to earnings ratio of 81.67. Meaning, the purchaser of the share is investing kr81.67 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.45%.
Sales Growth
NORBIT’s sales growth is 35.6% for the present quarter and 33.5% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 5, 2023, the estimated forward annual dividend rate is 0.7 and the estimated forward annual dividend yield is 1.88%.
More news about NORBIT.
5. RANA GRUBER (RANA.OL)
24.5% sales growth and 68.94% return on equity
Rana Gruber ASA engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. It also produces magnetite iron oxide concentrates. The company offers its products under the Colorana brands. It exports its products worldwide. Rana Gruber ASA was founded in 1937 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, RANA GRUBER has a trailing twelve months EPS of kr7.3.
PE Ratio
RANA GRUBER has a trailing twelve months price to earnings ratio of 8.22. Meaning, the purchaser of the share is investing kr8.22 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 68.94%.
Volume
Today’s last reported volume for RANA GRUBER is 26920 which is 84.09% below its average volume of 169299.
More news about RANA GRUBER.
6. FRØY (FROY.OL)
14% sales growth and 10.16% return on equity
Frøy ASA provides integrated service to the aquaculture industry in Norway. The company offers wellboat services, sea freight, de-lice and treatment, mooring and laying, ring washing and cage services, net washing and mending, inspection and certification, bottom mapping and documentation, slep, diving and ROV, and control system. It owns and operates 18 wellboats, 60 aqua service vessels, 3 feed transport vessels, and 13 local offices along the Norwegian coast. The company was founded in 2019 and is headquartered in Sistranda, Norway.
Earnings Per Share
As for profitability, FRØY has a trailing twelve months EPS of kr98.71.
PE Ratio
FRØY has a trailing twelve months price to earnings ratio of 0.66. Meaning, the purchaser of the share is investing kr0.66 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.16%.
Yearly Top and Bottom Value
FRØY’s stock is valued at kr65.40 at 17:20 EST, below its 52-week high of kr67.70 and way higher than its 52-week low of kr31.70.
Moving Average
FRØY’s value is higher than its 50-day moving average of kr61.08 and way higher than its 200-day moving average of kr48.48.
Revenue Growth
Year-on-year quarterly revenue growth grew by 35.9%, now sitting on 2.02B for the twelve trailing months.
More news about FRØY.
7. WEBSTEP (WSTEP.OL)
11.6% sales growth and 11.66% return on equity
Webstep ASA, together with its subsidiaries, provides information technology (IT) consultancy services to public and private businesses in Norway and Sweden. The company offers digitalization, cloud migration and integration, Internet of Things, machine learning, IT security, robotics, and analytics. Its services include consulting, digitalization, .Net, Java, open source, full stack, front and back end, user experience, integration, mobility, cloud apps, machine learning, business intelligence, big data, data warehousing, virtual robotics, Devops, application service management, and data science services; and cloud computing, cloud services, integration, sensor technology, product and service development, Beacons, enterprise user experience, web analysis, design team, Amazon Web, Azure, prediction, AI, mobility predictive modelling, predictive modelling, hackathon, business analysis, and search engine optimization services. The company serves banking, finance and insurance, public administration, agriculture and food production, IT and telecommunication, commerce, and transportation industries. The company was founded in 2000 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, WEBSTEP has a trailing twelve months EPS of kr1.38.
PE Ratio
WEBSTEP has a trailing twelve months price to earnings ratio of 22.66. Meaning, the purchaser of the share is investing kr22.66 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.66%.
Volume
Today’s last reported volume for WEBSTEP is 8023 which is 64.83% below its average volume of 22814.
More news about WEBSTEP.
8. EQUASENS (EQS.PA)
11.3% sales growth and 28.59% return on equity
Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.59%.
Yearly Top and Bottom Value
EQUASENS’s stock is valued at €71.50 at 17:20 EST, way under its 52-week high of €90.60 and way higher than its 52-week low of €57.80.
More news about EQUASENS.
